This is a standard insider filing with no trading implications. Monitor for any subsequent Form 4 filings that may indicate open-market transactions.
Price Chart
Executive Summary
Robert Weinstein filed a Form 3 initial statement of beneficial ownership with the SEC, disclosing 636,004 shares of Petros Pharmaceuticals common stock, including restricted shares and RSUs. This is a routine insider filing with no material financial information or trading signal.
Key Facts
- Robert Weinstein filed a Form 3 as a new insider (Chief Accounting Officer) on June 25, 2026.
- Reports beneficial ownership of 636,004 shares of common stock.
- Includes 6,004 restricted shares (3,004 vested, remainder vesting Feb 2, 2027), 315,000 vested RSUs, and 315,000 unvested RSUs (vesting schedule provided).
Financial Impact
No financial impact; routine initial ownership disclosure.
Risk Factors
- None from this filing; standard compliance filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001104659-26-077822 |
| Document: 0001104659-26-077822-index.html | 0001104659-26-077822 |
| Document: 0001104659-26-077822.txt | 0001104659-26-077822 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 30, 2026 27d ago | 8-K | $0.003000 $0.003000 | · 0.00% | ▲ +1.30% | $0.001900 (+36.67%) |
Jun 25, 2026 17w ago | 3 | $0.006000 $0.005000 | ▼ −16.67% | ▼ −18.83% | $0.001900 (−68.33%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers